These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2907487)

  • 21. Acute and chronic administration of the selective D(3) receptor antagonist SB-277011-A alters activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study.
    Ashby CR; Minabe Y; Stemp G; Hagan JJ; Middlemiss DN
    J Pharmacol Exp Ther; 2000 Sep; 294(3):1166-74. PubMed ID: 10945873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The D-1 antagonist SCH 23390 stimulates while the D-1 agonist SKF 38393 fails to affect dopamine release in the dorsal caudate of freely moving rats.
    Imperato A; Mulas A; Di Chiara G
    Eur J Pharmacol; 1987 Oct; 142(1):177-81. PubMed ID: 2891544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute depolarization block of A10 dopamine neurons: interactions of morphine with dopamine antagonists.
    Henry DJ; Wise RA; Rompré PP; White FJ
    Brain Res; 1992 Nov; 596(1-2):231-7. PubMed ID: 1467986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of acute and chronic LY 277359, a selective 5-HT3 receptor antagonist, on the number of spontaneously active midbrain dopamine neurons.
    Minabe Y; Ashby CR; Wang RY
    Eur J Pharmacol; 1991 Dec; 209(3):151-6. PubMed ID: 1797560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute and chronic administration of the selective 5-HT1A receptor antagonist WAY-405 significantly alters the activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study.
    Minabe Y; Schechter L; Hashimoto K; Shirayama Y; Ashby CR
    Synapse; 2003 Dec; 50(3):181-90. PubMed ID: 14515335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of tiaspirone (BMY-13859) and a chemical congener (BMY-13980) on A9 and A10 dopamine neurons in the rat.
    White FJ; Wang RY
    Neuropharmacology; 1986 Sep; 25(9):995-1001. PubMed ID: 2877417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential effects of acute clozapine and haloperidol on the activity of ventral tegmental (A10) and nigrostriatal (A9) dopamine neurons.
    Hand TH; Hu XT; Wang RY
    Brain Res; 1987 Jul; 415(2):257-69. PubMed ID: 3607497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. D1 receptor stimulation inhibits dopamine cell activity after reserpine treatment but not after chronic SCH 23390: an effect blocked by N-methyl-D-aspartate antagonists.
    Huang KX; Walters JR
    J Pharmacol Exp Ther; 1992 Jan; 260(1):409-16. PubMed ID: 1530977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of 5-HT(2A) receptor antagonism in amphetamine-induced inhibition of A10 dopamine neurons in vitro.
    Olijslagers JE; Perlstein B; Werkman TR; McCreary AC; Siarey R; Kruse CG; Wadman WJ
    Eur J Pharmacol; 2005 Sep; 520(1-3):77-85. PubMed ID: 16154561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the action of the stereoisomers of the psychostimulant 4-methylaminorex (4-MAX) on midbrain dopamine cells in the rat: an extracellular single unit study.
    Ashby CR; Pan H; Minabe Y; Toor A; Fishkin L; Wang RY
    Synapse; 1995 Aug; 20(4):351-61. PubMed ID: 7482294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The depletion of brain serotonin levels by para-chlorophenylalanine administration significantly alters the activity of midbrain dopamine cells in rats: an extracellular single cell recording study.
    Minabe Y; Emori K; Ashby CR
    Synapse; 1996 Jan; 22(1):46-53. PubMed ID: 8822477
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the effects of chronic haloperidol treatment on A9 and A10 dopamine neurons in the rat.
    White FJ; Wang RY
    Life Sci; 1983 Feb; 32(9):983-93. PubMed ID: 6827927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic treatment with SCH 23390, a selective dopamine D-1 receptor antagonist, decreases dopamine metabolism in rat caudate nucleus.
    Koulu M; Lappalainen J; Pesonen U; Hietala J; Syvälahti E
    Eur J Pharmacol; 1988 Oct; 155(3):313-6. PubMed ID: 3069483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Irreversible receptor inactivation reveals differences in dopamine receptor reserve between A9 and A10 dopamine systems: an electrophysiological analysis.
    Cox RF; Waszczak BL
    Brain Res; 1990 Nov; 534(1-2):273-82. PubMed ID: 1981482
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Repeated administration of Sigma ligands alters the population activity of rat midbrain dopaminergic neurons.
    Zhang J; Chiodo LA; Wettstein JG; Junien JL; Freeman AS
    Synapse; 1993 Mar; 13(3):223-30. PubMed ID: 8497808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of chronic SCH 23390 treatment on dopamine autoreceptor function in rat brain.
    Lappalainen J; Hietala J; Sjöholm B; Syvälahti E
    Eur J Pharmacol; 1990 Apr; 179(3):315-21. PubMed ID: 1973105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Morphine-induced activation of A10 dopamine neurons in the rat.
    Gysling K; Wang RY
    Brain Res; 1983 Oct; 277(1):119-27. PubMed ID: 6315137
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design and synthesis of trans-3-(2-(4-((3-(3-(5-methyl-1,2,4-oxadiazolyl))- phenyl)carboxamido)cyclohexyl)ethyl)-7-methylsulfonyl-2,3,4,5-tetrahydro-1H-3-benzazepine (SB-414796): a potent and selective dopamine D3 receptor antagonist.
    Macdonald GJ; Branch CL; Hadley MS; Johnson CN; Nash DJ; Smith AB; Stemp G; Thewlis KM; Vong AK; Austin NE; Jeffrey P; Winborn KY; Boyfield I; Hagan JJ; Middlemiss DN; Reavill C; Riley GJ; Watson JM; Wood M; Parker SG; Ashby CR
    J Med Chem; 2003 Nov; 46(23):4952-64. PubMed ID: 14584946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic treatment with SCH 23390 and haloperidol: effects on dopaminergic and serotonergic mechanisms in rat brain.
    Lappalainen J; Hietala J; Koulu M; Seppälä T; Sjöholm B; Syvälahti E
    J Pharmacol Exp Ther; 1990 Feb; 252(2):845-52. PubMed ID: 2179533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SCH 23390, a selective D1 dopamine receptor blocker, enhances the firing rate of nigral dopaminergic neurons but fails to activate striatal tyrosine hydroxylase.
    Onali P; Mereu G; Olianas MC; Bunse B; Rossetti Z; Gessa GL
    Brain Res; 1985 Aug; 340(1):1-7. PubMed ID: 2862956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.